3-acetamido-6-acetyl-2-nitrophenyl 4-(dimethylamino)benzoate | 1352289-21-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 缩酚酸和缩酚酸环醚类
• 英文名称: 3-acetamido-6-acetyl-2-nitrophenyl 4-(dimethylamino)benzoate
• 英文别名: (3-acetamido-6-acetyl-2-nitrophenyl) 4-(dimethylamino)benzoate
• CAS: 1352289-21-4
• 化学式: C₁₉H₁₉N₃O₆
• 分子量: 385.376
• InChiKey: QKGHHDFRQLLZHV-UHFFFAOYSA-N

物化性质

• 沸点：
  676.0±55.0 °C(Predicted)
• 密度：
  1.341±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  28
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  122
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  3-acetamido-6-acetyl-2-nitrophenyl 4-(dimethylamino)benzoate 在 palladium 10% on activated carbon 吡啶 、 盐酸 、 硫酸 、 氢气 、 溶剂黄146 、 potassium hydroxide 作用下， 以 水 为溶剂， 反应 1.5h， 生成 7,8-diamino-2-(4-(dimethylamino)phenyl)-4H-chromen-4-one hydrochloride
  参考文献：
  名称：

  [EN] TRKB AGONISTS AND METHODS OF USE
  [FR] AGONISTES TRKB ET LEURS PROCÉDÉS D'UTILISATION

  摘要：

  公开号：

  WO2011156479A9
• 作为产物：
  描述：

  4-二甲基氨基苯甲酰氯盐酸盐 、 N-(4-acetyl-3-hydroxy-2-nitrophenyl) acetamide 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 3.0h， 以75%的产率得到3-acetamido-6-acetyl-2-nitrophenyl 4-(dimethylamino)benzoate
  参考文献：
  名称：

  [EN] TRKB AGONISTS AND METHODS OF USE
  [FR] AGONISTES TRKB ET LEURS PROCÉDÉS D'UTILISATION

  摘要：

  公开号：

  WO2011156479A9

文献信息

• [EN] HETEROCYCLIC FLAVONE DERIVATIVES, COMPOSITIONS, AND METHODS RELATED THERETO<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES DE FLAVONE, COMPOSITIONS ET PROCÉDÉS S'Y RAPPORTANT
  申请人：UNIV EMORY

  公开号：WO2014018741A1

  公开（公告）日：2014-01-30

  In certain embodiments, the disclosure relates to heterocyclic flavone derivatives, such as those described by formula provided herein, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of 5 treating or preventing diseases or conditions related to BDNF and TrkB activity, such as depression, stroke, Rett syndrome, Parkinson's disease, and Alzheimer's disease by administering effective amounts of pharmaceutical compositions comprising compounds disclosed herein to a subject in need thereof.

  在某些实施例中，该公开涉及杂环黄酮衍生物，例如本文提供的公式所描述的那些，药物组合物以及相关方法。在某些实施例中，该公开涉及治疗或预防与BDNF和TrkB活性相关的疾病或症状的方法，例如抑郁症、中风、雷特综合征、帕金森病和阿尔茨海默病，通过向需要的受试者施用包含本文所披露的化合物的药物组合物的有效剂量。
• TRKB AGONISTS AND METHODS OF USE
  申请人：Ye Keqiang

  公开号：US20130040947A1

  公开（公告）日：2013-02-14

  Compounds and methods related to the activation of the TrkB receptor are provided. The methods include administering a 7,8-di-hydroxyflavone derivative with modified flavone or heterocyclic ring to a subject in need thereof. Methods and compounds for the treatment of disorders including neurologic disorders, neuropsychiatric disorders, and metabolic disorders (e.g., obesity) are provided.

  本文提供与TrkB受体激活相关的化合物和方法。这些方法包括将带有改性黄酮或杂环环的7,8-二羟基黄酮衍生物注射给需要的受试者。本文还提供了治疗神经系统疾病、神经精神疾病和代谢性疾病（例如肥胖症）的方法和化合物。
• HETEROCYCLIC FLAVONE DERIVATIVES, COMPOSITIONS, AND METHODS RELATED THERETO
  申请人：EMORY UNIVERSITY

  公开号：US20150191481A1

  公开（公告）日：2015-07-09

  In certain embodiments, the disclosure relates to heterocyclic flavone derivatives, such as those described by formula provided herein, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of 5 treating or preventing diseases or conditions related to BDNF and TrkB activity, such as depression, stroke, Rett syndrome, Parkinson's disease, and Alzheimer's disease by administering effective amounts of pharmaceutical compositions comprising compounds disclosed herein to a subject in need thereof.

  在某些实施方式中，本公开涉及杂环类黄酮衍生物，例如所述的公式所描述的那些，以及与之相关的药物组合物和方法。在某些实施方式中，本公开涉及通过向需要治疗或预防与BDNF和TrkB活性有关的疾病或病况，例如抑郁症、中风、雷特综合征、帕金森病和阿尔茨海默病的患者施用包含本文所披露的化合物的有效量的药物组合物的方法。
• TRKB agonists and methods of use
  申请人：Ye Keqiang

  公开号：US09029561B2

  公开（公告）日：2015-05-12

  Compounds and methods related to the activation of the TrkB receptor are provided. The methods include administering a 7,8-dihydroxyflavone derivative with modified flavone or heterocyclic ring to a subject in need thereof. Methods and compounds for the treatment of disorders including neurologic disorders, neuropsychiatric disorders, and metabolic disorders (e.g., obesity) are provided.

  提供与激活TrkB受体相关的化合物和方法。这些方法包括向需要的受试者施用经过改良的黄酮或杂环环7,8-二羟基黄酮衍生物。提供用于治疗神经学疾病、神经精神疾病和代谢性疾病（例如肥胖症）的方法和化合物。
• Heterocyclic flavone derivatives, compositions, and methods related thereto
  申请人：Emory University

  公开号：US10010526B2

  公开（公告）日：2018-07-03

  In certain embodiments, the disclosure relates to heterocyclic flavone derivatives, such as those described by formula provided herein, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing diseases or conditions related to BDNF and TrkB activity, such as depression, stroke, Rett syndrome, Parkinson's disease, and Alzheimer's disease by administering effective amounts of pharmaceutical compositions comprising compounds disclosed herein.

  在某些实施方案中，本公开涉及杂环黄酮衍生物，如本文提供的式中描述的那些衍生物、药物组合物及其相关方法。在某些实施方案中，本公开涉及通过施用有效量的包含本文所公开化合物的药物组合物来治疗或预防与 BDNF 和 TrkB 活性有关的疾病或病症的方法，如抑郁症、中风、Rett 综合征、帕金森病和阿尔茨海默病。